| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/19/2001 | CA2366411A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 07/18/2001 | EP1116733A1 Water-soluble or water-swellable crosslinked copolymers |
| 07/18/2001 | EP1116516A1 Templating of solid particles by polymer multilayers |
| 07/18/2001 | EP1116485A2 Instant granulate and process for its preparation |
| 07/18/2001 | EP1116483A1 Oil-in-water emulsion composition |
| 07/18/2001 | EP1115818A1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 07/18/2001 | EP1115748A1 Carrageenan compositions, and processes for their production |
| 07/18/2001 | EP1115747A1 Polymer complexes of glucuronoglucanes |
| 07/18/2001 | EP1115478A2 Emollient esters based upon capryl alcohol and isostearic acid |
| 07/18/2001 | EP1115433A1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same |
| 07/18/2001 | EP1115428A1 Cationic compounds and their use as macro molecular carriers |
| 07/18/2001 | EP1115409A1 Composition for extending post meal satiety |
| 07/18/2001 | EP1115406A2 Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 07/18/2001 | EP1115384A1 Fentanyl composition for the treatment of acute pain |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP1115381A1 Proteinic drug delivery system using membrane mimetics |
| 07/18/2001 | EP1115380A2 Micronised pharmaceutical compositions |
| 07/18/2001 | EP1115379A2 Liquid pharmaceutical for oral delivery |
| 07/18/2001 | EP1115378A1 Oral mucoadhesive compositions containing gastrointestinal actives |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP1115296A1 Nutritional and pharmaceutical compositions |
| 07/18/2001 | EP1115295A2 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
| 07/18/2001 | EP0949905B1 Injectable depot gel composition and method of preparing the composition |
| 07/18/2001 | EP0928196A4 Beta-glucan products and extraction processes from cereals |
| 07/18/2001 | EP0758235B1 Polymer coated tablet comprising amoxycillin and clavulanate |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | EP0639083B1 Complexing agents and targeting immunoreagents |
| 07/18/2001 | EP0616508B1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/18/2001 | CN1304423A Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polythylene glycol, and polyorthoester-polyethylene-glycol-polyorthoester block cpolymers |
| 07/18/2001 | CN1304416A Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and use |
| 07/18/2001 | CN1304322A Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 07/18/2001 | CN1304321A Composition for transdermal administration of non-steroidal anti-inflammatory drugs |
| 07/18/2001 | CN1304317A Nucleic acid encoding hyaluronan synthase and method of use |
| 07/18/2001 | CN1304310A Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 07/18/2001 | CN1303670A Product with powder stable vitamine and/or carotenoid and its producing process |
| 07/18/2001 | CN1068585C Cationic lipids for gene therapy |
| 07/17/2001 | USRE37285 Polyoxypropylene/polyoxyethylene copolmers with improved biological activity |
| 07/17/2001 | US6262253 Vitamin B12 conjugates with gcsf, analogues thereof and pharmaceutical compositions |
| 07/17/2001 | US6262241 Antisense compounds which cleave phosphorodiester bonds and improve pharmacodynamic and pharmacokinetic properties of oligonucleotides, useful in diagnosing diseases |
| 07/17/2001 | US6262172 Method for preparing a carbonized resin DNA immunoadsorbent |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262126 Semi-fluorinated alkanes and their use |
| 07/17/2001 | US6262121 Oily patches for external use containing diclofenac sodium |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6262092 Mutual salt of amlodipine and atorvastatin |
| 07/17/2001 | US6262086 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole; antisecretory agents |
| 07/17/2001 | US6262085 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/17/2001 | US6262079 Prevention and treatment of cardiovascular pathologies |
| 07/17/2001 | US6262022 Carrier medium comprises: 1,2-propylene glycol; mixture of c.sub.12-20 fatty acid mono-, di-, and tri-glycerides; surfactant. |
| 07/17/2001 | US6261787 Bifunctional molecules for delivery of therapeutics |
| 07/17/2001 | US6261765 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 07/17/2001 | US6261602 Pharmaceutical composition for rapid suspension in aqueous media |
| 07/17/2001 | US6261600 Mixture containing neutralized alkaline compound |
| 07/17/2001 | US6261599 Sustained release |
| 07/17/2001 | US6261598 Carotenoid formulations, comprising a mixture of B-carotens, lycopene and lutein |
| 07/17/2001 | US6261594 Chitosan-based nitric oxide donor compositions |
| 07/17/2001 | US6261591 Method for reducing hip joint laxity |
| 07/17/2001 | US6261588 Administering mushroom extract |
| 07/17/2001 | US6261587 Contacting with matrix containing gelatin and nitric acid inhibitor |
| 07/17/2001 | US6261583 Moldable solid delivery system |
| 07/17/2001 | US6261582 Analgesic paste containing collagen |
| 07/17/2001 | US6261577 Topical applying mixture of iodine and halide |
| 07/17/2001 | US6261561 Administering intimin or fusion protein |
| 07/17/2001 | US6261554 Compositions for targeted gene delivery |
| 07/17/2001 | US6261547 Solutions for vision defects, anesthetics |
| 07/17/2001 | US6261546 Methods and compositions for stabilizing acetylcholine compositions |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | US6261539 Medicine, propellants, stabilizers and dispersants |
| 07/17/2001 | US6261537 Targets and ultrasound diagnosis of active materials, aqueous carrier liquids, carriers and film forming surfactant phosphatides |
| 07/17/2001 | US6261535 Images of tumors |
| 07/17/2001 | CA2261500C Stable oxaliplatin solutions and their use in cytostatic antineoplastic treatment |
| 07/17/2001 | CA2173543C Ceramide-type compounds, process for their preparation and uses thereof |
| 07/17/2001 | CA2034197C Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/17/2001 | CA2034025C Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/12/2001 | WO2001049885A1 EGS MOLECULES THAT SPECIFICALLY DOWNREGULATE bcl-xL EXPRESSION |
| 07/12/2001 | WO2001049869A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | WO2001049867A1 M cell directed vaccines |
| 07/12/2001 | WO2001049841A1 Polyampholytes for delivering polyions to a cell |
| 07/12/2001 | WO2001049705A2 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | WO2001049696A1 N,o-amidomalonate platinum complexes |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049324A2 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | WO2001049314A2 Glp-2 formulations |
| 07/12/2001 | WO2001049311A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049296A1 Antimicrobial compositions and methods of use |
| 07/12/2001 | WO2001049292A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | WO2001049286A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 07/12/2001 | WO2001049283A1 Preparations for the non-traumatic excision of a nail |
| 07/12/2001 | WO2001049274A2 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | WO2001049273A2 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation |
| 07/12/2001 | WO2001049272A2 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| 07/12/2001 | WO2001049270A2 Odor-masking coating for a pharmaceutical preparation |
| 07/12/2001 | WO2001049269A1 Sustained-releasing anthelmintic compositions comprising praziquantel |
| 07/12/2001 | WO2001049268A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | WO2001049264A2 Pharmaceutical compositions for oral administration |
| 07/12/2001 | WO2001049262A1 Fenofibrate galenic formulations and method for obtaining same |
| 07/12/2001 | WO2001049261A2 Stable aqueous deoxyfructosazine solution |